LACOSAMIDE
NDC 72865-235, LACOSAMIDE, injection, from XLCare Pharmaceuticals Inc..
- Product NDC
- 72865-235
- Status
- Listed
- Labeler
- XLCare Pharmaceuticals Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216335
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/72865-235 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE10 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72865-235-10 | 72865023510 | 10 VIAL, GLASS in 1 CARTON (72865-235-10) / 20 mL in 1 VIAL, GLASS (72865-235-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c7793da3-787b-4364-9192-7caab49066f1
Use it
Look up 72865-235 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72865-235 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72865-235. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.